Who invested in Axonis Therapeutics

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$115Mraised across 1 round since 2024, from 1 source

Latest round: Series A, $115MOct 2024
Investors: 4

See who backed them

The rounds

Oct 2024
Series A$115M
Source recordedSEC filing: $46M sold, first sale Oct 2024

Founders and team

From Axonis Therapeutics's own website: 1 on the team.

Eos BioInnovationBoard Director

Everyone who backed them

MassChallengeAccelerator1round

Perceptive AdvisorsAsset manager1round

Cormorant Asset ManagementPrivate equity1round

Hatteras Venture PartnersVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Axonis Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Iaso VenturesVC firmPer its own site

Quick answers about Axonis Therapeutics

Who invested in Axonis Therapeutics?

Axonis Therapeutics's investors include MassChallenge, Perceptive Advisors, Cormorant Asset Management and Hatteras Venture Partners.

How much has Axonis Therapeutics raised?

Axonis Therapeutics has raised $115M across 1 round since 2024.

When did Axonis Therapeutics last raise?

Axonis Therapeutics's most recent round was a Series A of $115M in Oct 2024.

What was Axonis Therapeutics's biggest round?

Its most recent round, $115M in Oct 2024, is also its largest on record.

Who backed Axonis Therapeutics first?

Axonis Therapeutics's first round on record, in Oct 2024, was backed by MassChallenge, Perceptive Advisors and Cormorant Asset Management and 1 others.